Oral Findings In A Group of Egyptian Children With Attention Deficit Hyperactivity Disorder

Oral Manifestations Clinical Trial

Official title:

Oral Findings In A Group of Egyptian Children With Attention Deficit Hyperactivity Disorder: A Cross-Sectional Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03887039
• Other study ID #: 14422016496994
• Status: Not yet recruiting
• Start date: August 2019
• Est. completion date: July 2020

Study information

• Verified date: March 2019
• Source: Cairo University
• Contact: sara G hussien, BSc
• Phone: 00201012120090
• Email: Sara.Gaber[@]dentistry.cu.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Attention-deficit/hyperactivity disorder is the most common childhood neuro-developmental disorder that is characterized by inattention, hyperactivity, and impulsivity. These symptoms last till adulthood in 65% of cases. ADHD has been reported to have a worldwide prevalence of 5.3% and it is more common in boys than in girls (Ghanizadeh 2008; Serra-Negra et al. 2012 and Shooshtari et al. 2013) The symptoms of ADHD are generally treated through behavioral therapy, with or without pharmacological intervention. Medications prescribed are commonly divided into stimulant or non-stimulant drugs. The stimulant medications (such as methylphenidate and amphetamines) have been implicated in adverse oral effects, such as xerostomia and gingival enlargement. The current evidence is controversial regarding the severity and prevalence of dental caries, dental trauma, periodontal diseases, oral habits and tooth wear among patients with ADHD (Chau et al. 2017).

In the Arab world, few studies have been published on ADHD. Accordingly, in the Arab society and Egypt there are limited data regarding the oral findings of children with ADHD. Owing to the sparsity of these data, this study will be conducted to evaluate different oral characteristics of Egyptian children with ADHD.

Description:

Due to lack of published studies about the oral findings of Egyptian Children with ADHD, this study will be conducted to cover this point.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 78
• Est. completion date: July 2020
• Est. primary completion date: June 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 3 Years to 6 Years

Eligibility

Inclusion Criteria:

• - Egyptian children 3-6 years old diagnosed with ADHD.

• Patients taking medications for the treatment of ADHD or not.

• Both male and female patients will be included.

Control Group:

A matched group of healthy children aged 3-6 years old.

Exclusion Criteria:

• - Non-Egyptian children.

• Patients having systemic disorders, such as cerebral palsy or Down's syndrome.

• Patients complaining from any systemic disease

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Oral Manifestations

Intervention

Other:
• clinical examination
clinical examination for all the oral findings

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	oral habits	clinical examination yes/no	6 months
Secondary	DMFT caries index	DMFT D=dacayed M=missed due to caries F=filled T=tooth score 0-20 for primary teeth0 is the best / 20 is the worst	6 months
Secondary	dental trauma	clinical examination yes/no	6 months